First report 2h ago•Last update 2h ago
UK Government's Awareness of Blood Clot Risks in AstraZeneca COVID-19 Vaccine Trials on Children
Reports indicate the UK government was aware of potential fatal blood clot risks but allowed AstraZeneca's COVID-19 vaccine trials on children to proceed in 2021.
Background
The COVID-19 pandemic led to a global push for rapid vaccine development and trials. Governments worldwide faced the challenge of balancing public health needs with safety concerns, particularly regarding vulnerable populations like children. This context highlights the scrutiny around regulatory decisions during a public health crisis.
Quorum · collective opinions
Concerns Over COVID-19 Vaccine Trials in UK Children
First report 7h agoLast update 7h ago1 takes▼ 1
criticism of vaccine policynegativeShow 1 post
started 7h ago•Last update 7h ago
There is criticism regarding the continuation of COVID-19 vaccine trials on children despite known risks, questioning the government's decision-making.
iWitness comments
No comments yet — be the first to weigh in.